This week, The Guardian reported on a growing concern the Trump administration may be pressuring government agencies including the FDA to approve a COVID-19 vaccine in time for the US election
Today, an unnamed source in the White House administration spoke with Yahoo News taking a different tone, "We cannot promise a 100 percent chance of success.” Since then...
According to a report in the New York Times today, the White House has selected five pharmaceutical companies as finalists for funding for “Operation Warp Speed.”
In a press release yesterday, US company Emergent BioSolutions announced they have been called upon by the US government under their existing contract to support Trump's controversially aggressive "Project Warpspeed."
The Trump administration's Project Warp speed jeopardizes the safety of vaccines being developed. The project aims to have 300 million vaccines available by early January, a process which normally takes three years of phased development.